COMPANY
MSN LIFE SCIENCES PRIVATE LTD
MSN LIFE SCIENCES PRIVATE LTD: API manufacturer for Abaloparatide, Difelikefalin, Etelcalcetide, Exenatide, Icatibant, Linaclotide, Plecanatide, Semaglutide, Teduglutide, Teriparatide, Tirzepatide, as stated by public registers.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Abaloparatide | DMF 34697, type II, active, submitted 2020-05-30 Regulator FDA drug master file list |
|---|---|
| Difelikefalin | DMF 40537, type II, active, submitted 2024-09-27 Regulator FDA drug master file list |
| Etelcalcetide | DMF 35097, type II, active, submitted 2020-09-01 Regulator FDA drug master file list |
| Exenatide | DMF 34566, type II, active, submitted 2020-02-17 Regulator FDA drug master file list |
| Icatibant | DMF 30672, type II, active, submitted 2016-07-25 Regulator FDA drug master file list |
| Linaclotide | DMF 30421, type II, inactive, submitted 2016-03-29 Regulator FDA drug master file list |
| Linaclotide | DMF 31351, type II, active, submitted 2017-02-01 Regulator FDA drug master file list |
| Plecanatide | DMF 34049, type II, active, submitted 2019-09-11 Regulator FDA drug master file list |
| Semaglutide | DMF 38729, type II, active, submitted 2023-09-23 Regulator FDA drug master file list |
| Teduglutide | DMF 37596, type II, active, submitted 2022-12-15 Regulator FDA drug master file list |
| Teriparatide | DMF 34713, type II, active, submitted 2020-09-01 Regulator FDA drug master file list |
| Tirzepatide | DMF 43540, type II, active, submitted 2026-02-11 Regulator FDA drug master file list |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.